BCR-ABL insufficiency for the transformation of human stem cells into CML

Medical Hypotheses

Volumn 59, Issue 5, 2002, Pages 588-589

  Matioli, G T ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; IMATINIB; PLATELET DERIVED GROWTH FACTOR; STEM CELL FACTOR;

ARTICLE; CELL DIFFERENTIATION; CELL FATE; CELL KINETICS; CELL TRANSFORMATION; CHRONIC MYELOID LEUKEMIA; DATA ANALYSIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MATHEMATICAL COMPUTING; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN SECRETION; STEM CELL; ADULT; BIOLOGICAL MODEL; CANCER STEM CELL; GENETICS; GRANULOCYTE; MYELOID LEUKEMIA; PATHOLOGY; PHYSIOLOGY; REFERENCE VALUE;

ADULT; CELL TRANSFORMATION, NEOPLASTIC; FUSION PROTEINS, BCR-ABL; GRANULOCYTES; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MODELS, BIOLOGICAL; REFERENCE VALUES; TUMOR STEM CELLS;

EID: 0036838586     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(02)00220-7     Document Type: Article

References (8)

1. Biernaux C., Loos M., Sels A., Huez G., Stryckmans P. Detection of major BCR-Abl gene expression at a very low level in blood cells of some healthy individuals. Blood 1995; 86: 3118.
2. Bose S., Deininger M., Tybor J. G., Goldman J. M., Melo J. V. The presence of typical and atypical BCR-Abl fusion genes in leukocytes of normal individuals: Biologic significance and implications for the assessment of minimal residual disease. Blood 1998; 92: 3362.
3. Cho E. K., Heo D. S., Seol J. G., Seo E. J. et al. Ontogeny of natural killer cells and T cells by analysis of BCR-Abl rearrangement from patients with chronic myelogenous leukemia. Brit J Hemat 2000; 111: 215.
4. Au W. Y., Lie A. K. W., Ma S. K., Wan T. S. K., Liang R., Leung Y. H., Kwong Y. L. Phyladelphia (Ph) chromosome-positive CML relapsing as Ph-negative leukemia after allogenic marrow transplantation. Brit J Hemat 2001; 114: 365.
5. Kramer A., Loffler H., Bergmann J., Hochhaus A., Hehlmann R. Proliferating status of peripheral blood progenitor cells from patients with BCR-Abl positive chronic Myelogenous leukemia. Leukemia 2001; 15: 62.
6. Goldman J. M., Melo J. V. Targeting the BCR-Abl tyrosine kinase in CML. New Eng J Med 2001; 344: 1084.
7. Joensuu H., Robert P. J., Sarlomo-Rikalam et al. Effect of the tyrosine kinase inhibitor STI 571 in a patient with a metastatic gastrointestinal stromal tumor. N Eng J Med 2001; 344: 1052.
8. Matioli G. T. Go and chemoresistance of malignant cells. Med. Hypotheses 2001; submitted